Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-17.88	55.03	-67.01
Graham Fair Price	-58.09	32.26	76.98
PEG	3733.12	-0.19	< 0.005
Price/Book	-12.99	3.60	4.13
Price/Cash Flow	83.45	118.07	64.36
Prices/Earnings	395.66	21.91	-4.42
Price/Sales	-1.52	3.44	3.50
Price/FCF	83.45	118.07	64.36
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-4.10	0.31	0.32
Operating Margin	-42.08	0.06	-0.10
ROA	-82.52	0.01	-0.08
ROE	-0.23	0.04	-82.45
ROIC	-0.06	0.03	-56.52
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.03	87.13
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-3.72	1.51	-59.41
EPS QOQ	-9.09	1.18	-87.07
FCF QOQ	14.23	-0.53	-96.30
Revenue QOQ	0.18	-0.12	-35.65
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	78.51	85.40	8.78
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	1.15	1.05	-8.08
Debt/Capitalization	0.40	0.40	-0.02
Quick Ratio	0.15	0.13	-10.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	33.56	33.57	0.04
Cash	3.14	2.84	-9.65
Capex	-3.60	-2.17	39.74
Free Cash Flow	2.16	1.02	-52.55
Revenue	39.65	35.04	-11.62
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.31	1.28	-2.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-16.28	14.87	-8.71
Naive Interpretation	Member

06 - Financial Health · Weak

Rating